Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01189 (
beta-endorphin
)
21,003
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The P-450 side chain cleavage (CYP11A1) gene encodes the enzyme that catalyzes the initial step in steroid biosynthesis, resulting in the conversion of cholesterol to pregnenolone. Expression of the CYP11A1 gene is increased by hormones, such as
adrenocorticotropin
and luteinizing hormone, as well as by a number of growth factors, suggesting that its promoter may contain regulatory elements that respond to multiple signal transduction pathways. Using transient expression assays of the ovine CYP11A1 promoter in JEG-3 placental cells, distinct regulatory elements were found to mediate transcriptional stimulation by cAMP and epidermal growth factor (EGF). The cAMP response was mediated through a GC-rich sequence localized between -117 and -92. In contrast, EGF induced CYP11A1 transcription through an adjacent but distinct sequence (-92 to -77 base pairs) that was shown previously to bind nuclear proteins in DNase I footprinting reactions. This EGF-responsive element (EGF-RE) resembles an activator protein-1 (AP-1) site and was also required for transactivation by co-transfected c-Jun. A point mutation within the EGF-RE impaired stimulation by both EGF and c-Jun, suggesting that these pathways converge on a common regulatory element. Transfer of single or multiple copies of the EGF-RE upstream of an heterologous promotor conferrd EGF and c-Jun responses, providing further evidence that this element is sufficient for both responses. Transfection studies employing mutant c-Jun proteins confirmed a requirement for its DNA binding,
leucine zipper
and amino-terminal domains, each of which are required for activation of a classical AP-1 reporter. Gel shift studies demonstrated that protein binding to the CYP11A1 EGF-RE was competed specifically by a canonical AP-1 site, and the addition of an anti-JUN antibody confirmed the presence of AP-1 proteins. Consistent with the possibility that EGF may act in part via c-Jun, EGF stimulated the activity of a chimeric GAL4 c-Jun protein, indicating that JUN can serve as a potential target of EGF in JEG-3 cells. EGF also induced mitogen-activated protein kinase activity, and a dominant negative mutant of mitogen-activated protein kinase partially blocked EGF stimulation of GAL4 c-Jun activity. We conclude that EGF stimulates the CYP11A1 promoter through an AP-1 like element and that c-Jun is one of the targets of EGF action.
...
PMID:Epidermal growth factor and c-Jun act via a common DNA regulatory element to stimulate transcription of the ovine P-450 cholesterol side chain cleavage (CYP11A1) promoter. 762 50
The microphthalmia (mi) locus encodes a member of the basic-helix-loop-helix-
leucine zipper
(bHLH-Zip) protein family of transcription factors (MITF). We have reported that expression of several genes was impaired in cultured mast cells (CMCs) of mi/mi mice due to a defective transactivation ability of mutant MITF (mi-MITF). We also found that mi/mi CMCs did not express a receptor (MC1R) for
alpha-melanocyte-stimulating hormone
. The overexpression of the wild-type (+/+) MITF but not mi-MITF normalized the expression of the MC1R in mi/mi CMCs, indicating the involvement of +-MITF in the MC1R gene expression. Next, we analyzed the promoter region of the MC1R gene by the transient cotransfection assay. The luciferase construct under the control of the MC1R promoter and the cDNA-encoding +-MITF or mi-MITF were cotransfected into NIH/3T3 fibroblasts. The cotransfection of +-MITF but not mi-MITF increased the luciferase activity. There were five CANNTG motifs recognized by bHLH-Zip-type transcription factors in the cloned promoter region. We found +-MITF bound two of five CANNTG motifs, and both motifs were essential for the transactivation of the MC1R gene by +-MITF. These results indicated that +-MITF directly transactivated the MC1R gene through these two motifs.
...
PMID:Involvement of mi-transcription factor in expression of alpha-melanocyte-stimulating hormone receptor in cultured mast cells of mice. 1062 32
Salt-inducible kinase (SIK), a serine/threonine protein kinase expressed at an early stage of
adrenocorticotropic hormone (ACTH)
stimulation in Y1 mouse adrenocortical tumor cells, repressed the cAMP-responsive element (CRE)-dependent gene transcription by acting on the basic
leucine zipper
domain of the CRE-binding protein (Doi, J., Takemori, H., Lin, X.-z., Horike, N., Katoh, Y., and Okamoto, M. (2002) J. Biol. Chem. 277, 15629-15637). The mechanism of SIK-mediated gene regulation has been further explored. Here we show that SIK changes its subcellular location after the addition of ACTH. The immunocytochemical and fluorocytochemical analyses showed that SIK was present both in the nuclear and cytoplasmic compartments of resting cells; when the cells were stimulated with ACTH the nuclear SIK moved into the cytoplasm within 15 min; the level of SIK in the nuclear compartment gradually returned to the initial level after 12 h. SIK translocation was blocked by pretreatment with leptomycin B. A mutant SIK whose Ser-577, the cAMP-dependent protein kinase (PKA)-dependent phosphorylation site, was replaced with Ala could not move out of the nucleus under stimulation by ACTH. As expected, the degree of repression exerted by SIK on CRE reporter activity was weak as long as SIK was present in the cytoplasmic compartment. The same was true for the SIK-mediated repression of a steroidogenic acute regulatory (StAR) protein-gene promoter, which contained a CRE-like sequence at -95 to -85 bp. These results suggest that in the ACTH-stimulated Y1 cells the nuclear SIK was PKA-dependently phosphorylated, and the phosphorylated SIK was then translocated out of the nuclei. This intracellular translocation of SIK, a CRE-repressor, may account for the time-dependent change in the level of ACTH-activated expression of the StAR protein gene.
...
PMID:ACTH-induced nucleocytoplasmic translocation of salt-inducible kinase. Implication in the protein kinase A-activated gene transcription in mouse adrenocortical tumor cells. 1220 Apr 23
The ontogeny of the corticotropin-releasing factor (CRF) system and of the ability of the hypothalamic-pituitary-interrenal (HPI) axis to respond to stressors (capture or confinement), or to cortisol treatment was investigated in tilapia (Oreochromis mossambicus). In 2 days post hatching (dph) larvae, the first developmental stage used for immunohistochemistry, CRF-immunoreactivity (ir) was observed in the nucleus preopticus (npo), and in two hypothalamic nuclei (nlt and
nrl
). In this stage, CRF- and AVT-ir was found in the neural part of the pituitary, and endocrine cells in the pars distalis and pars intermedia contained POMC-derived peptides. In the ventral telencephalon, CRF-ir cells were first observed 5 dph, whereas projections from these cells into the anterior part of the latero-dorsal telencephalon (Dla) from 7 dph onwards. CRF, ACTH,
alpha-MSH
, and cortisol were quantified by radioimmunoassays in homogenates of the anterior-cranial region of the larvae containing brain, pituitary, and headkidneys. CRF contents increased from 43 +/- 3 to 1070 +/- 70 pg/larvae between 5 and 110 dph. Larvae of age 5, 12, 24, and 42 dph were captured sequentially from a group. All life stages were able to rapidly increase their cortisol content in response to this stressor (ANOVA: P < 0.001). Overall, the developmental stage affected cortisol content (ANOVA: P < 0.001), but developmental stage did not influence the cortisol reaction to stress (ANOVA: P > 0.162). Whole brain CRF content did not change during the 20 min stress period and the relationship between CRF-producing neurons and the initial HPI stress response in early life stages remains to be established. Cortisol feeding of 18 and 29 dph larvae for periods ranging from 2 to 24 days resulted in elevations of the CRF content (P < 0.003) in comparison to controls. In 18 dph larvae cortisol feeding abolished the cortisol response to capture stress as observed in control fed larvae (P < 0.008). We propose that cortisol induced upregulation of CRF takes place in the telencephalon and is restricted to a time period during larval development, characterised by the absence of glucocortoid receptor (GR) expression in the telencephalic Dm region in these larvae. Finally, the stress response to 24 h confinement was compared between saltwater adapted and freshwater adapted juveniles (age 77 dph). Confinement stress (24 h) affected cortisol and CRF content (ANOVA: P < 0.001, P < 0.008, respectively), but not ACTH content. Interactions were observed between salinity and confinement regarding cortisol and
alpha-MSH
contents (ANOVA: P < 0.02), but not regarding CRF and ACTH contents. The increase in cortisol levels induced by confinement was remarkably high in freshwater adapted larvae (five times higher than in saltwater adapted larvae). Regarding the cortisol response it is concluded that during and after the period of mouth breeding tilapia larvae respond to capture stress in a similar fashion (onset and height) as adults. Previously, we reported that the initial plasma cortisol response to capture stress in adult tilapia occurred independently from changes in plasma ACTH levels. The current finding that also brain CRF contents do not alter during the initial cortisol response in larvae further indicates that the initial cortisol response in this species may be regulated independently from CRF and ACTH.
...
PMID:Ontogeny of corticotropin-releasing factor and of hypothalamic-pituitary-interrenal axis responsiveness to stress in tilapia (Oreochromis mossambicus; Teleostei). 1556 Aug 72